Does TAZOBACTAM Cause Hepatic cytolysis? 26 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 26 reports of Hepatic cytolysis have been filed in association with TAZOBACTAM. This represents 3.5% of all adverse event reports for TAZOBACTAM.
26
Reports of Hepatic cytolysis with TAZOBACTAM
3.5%
of all TAZOBACTAM reports
5
Deaths
13
Hospitalizations
How Dangerous Is Hepatic cytolysis From TAZOBACTAM?
Of the 26 reports, 5 (19.2%) resulted in death, 13 (50.0%) required hospitalization, and 5 (19.2%) were considered life-threatening.
Is Hepatic cytolysis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TAZOBACTAM. However, 26 reports have been filed with the FAERS database.
What Other Side Effects Does TAZOBACTAM Cause?
Pyrexia (84)
Drug ineffective (73)
Off label use (54)
Acute kidney injury (53)
Condition aggravated (51)
Platelet count decreased (48)
Neutrophil count increased (47)
Eosinophilia (40)
Chills (39)
Leukopenia (35)
What Other Drugs Cause Hepatic cytolysis?
ACETAMINOPHEN (1,469)
ATORVASTATIN (681)
PEMBROLIZUMAB (601)
CARBOPLATIN (577)
METHOTREXATE (468)
SULFAMETHOXAZOLE\TRIMETHOPRIM (356)
PACLITAXEL (324)
ENOXAPARIN (307)
AMOXICILLIN (273)
VALACYCLOVIR (261)
Which TAZOBACTAM Alternatives Have Lower Hepatic cytolysis Risk?
TAZOBACTAM vs TBO-FILGRASTIM
TAZOBACTAM vs TEBENTAFUSP-TEBN
TAZOBACTAM vs TECFIDERA
TAZOBACTAM vs TECHNETIUM TC-99M
TAZOBACTAM vs TECHNETIUM TC-99M MEDRONATE